ComInnex
ComInnex is a Budapest-based synthetic chemistry services provider, founded in 2009, that delivers novel chemical technologies and chemistry expertise to pharmaceutical and biotech clients in early-stage drug discovery. The firm operates with a small team of 1-10 employees.
- Company typePrivate
- Founded2009
- HeadquartersBudapest, Hungary
- Headcount1–10
- GTM typeB2B
- OfferingServices
What ComInnex does
ComInnex is a privately held synthetic chemistry services provider founded in 2009 and headquartered in Budapest, Hungary. The company supplies synthetic chemistry services and novel chemical technologies to support early-stage drug discovery, positioning itself as a contract research partner for pharmaceutical and biotechnology organizations that require specialized chemistry capabilities in the hit-to-lead and lead optimization phases of drug development.
The firm operates at a micro-scale, with a reported headcount of 1-10 employees, indicating a boutique, expert-driven delivery model rather than a scaled platform CRO. Leadership is centered on CEO Alexander Drijver. Source material describing the company's specific product portfolio, proprietary platforms, technology stack, pricing structure, and customer base was not retrievable — the company website presented a security verification/loading page rather than substantive content during data collection. No funding rounds, partnerships, patents, certifications, or regulatory actions are documented in the available input.
ComInnex's business model is consistent with a fee-for-service contract research organization (CRO) operating in the synthetic chemistry niche, but no pricing details, contract structures, or revenue mechanics were available for verification. The firm is privately held and has not announced an IPO. As of the available data, the company appears to be a specialized, small-scale European chemistry services provider serving the early-stage drug discovery market.
ComInnex firmographics
Firmographics- Name
- ComInnex
- Website
- https://cominnex.com
- Company type
- Private
- Founded year
- 2009
- Headcount range
- 1–10 employees
- Short description
- ComInnex is a Budapest-based synthetic chemistry services provider, founded in 2009, that delivers novel chemical technologies and chemistry expertise to pharmaceutical and biotech clients in early-stage drug discovery. The firm operates with a small team of 1-10 employees.
- Ownership category
- akta.pro rank
ComInnex industry classification
Industry- Product category
- Drug Discovery Chemistry Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
- SIC
- Services-Commercial Physical & Biological Research (8731), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Chiral / Asymmetric Synthesis & Complex Chemistry Services (HLAGAHAE)
- akta.pro secondary industry
- Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries) (HLAAAIAL)
Keywords
Where ComInnex is headquartered
LocationHeadquarters
- HQ city
- Budapest
- HQ country
- Hungary
- HQ region
- Europe
Markets served
ComInnex business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
ComInnex product offering
Product offeringCore offering
ComInnex provides synthetic chemistry services and develops novel chemical technologies to support early-stage drug discovery. The company's work underpins compound preparation, route development, and chemistry-enabled discovery activities performed on behalf of pharmaceutical and biotechnology clients.
Differentiator
Problem solved
Functional benefit
Products and services
- Synthetic chemistry services for drug discovery
Companies that use ComInnex
Customer profileIdeal customer profiles1 record
ComInnex technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
ComInnex partnerships and signals
Strategic signalRecent moves2 records
ComInnex competitors and assessment
Company assessmentDirect peers
- Selvita: Selvita is a Krakow, Poland-based contract research organization offering medicinal chemistry, custom synthesis, and integrated drug discovery services to biotech and pharma clients — directly comparable to ComInnex as a Central/Eastern European specialty chemistry CRO.
- ChemPartner: ChemPartner is a global CRO with strong synthetic and medicinal chemistry capabilities serving early-stage drug discovery programs, directly competing for the same biotech client base as ComInnex with comparable custom synthesis offerings.
- Sygnature Discovery: Sygnature Discovery is a UK-based drug discovery CRO offering medicinal chemistry, computational chemistry, and DMPK services, comparable to ComInnex in providing synthetic chemistry support for early-stage drug discovery.
- Sai Life Sciences: Sai Life Sciences is an India-headquartered CRO providing medicinal chemistry, process chemistry, and integrated discovery services for pharma and biotech — directly comparable to ComInnex in offering synthetic chemistry support for early-stage drug discovery.
- Aragen Life Sciences: Aragen (formerly GVK Biosciences) is an India-based CRO offering medicinal chemistry, custom synthesis, and integrated discovery services — directly competing with ComInnex for early-stage drug discovery chemistry programs.
- Concept Life Sciences: Concept Life Sciences is a UK-based discovery CRO providing medicinal chemistry, custom synthesis, and integrated drug discovery services — closely comparable to ComInnex as a mid-sized chemistry-focused discovery services provider.
- BioAscent: BioAscent is a UK-based integrated drug discovery CRO with medicinal chemistry, DMPK, and biology services — comparable to ComInnex as a similarly sized specialist discovery services firm serving biotech clients.
Broad incumbents
- Pharmaron: Pharmaron is a large global CRO offering end-to-end drug discovery and development services including synthetic and medicinal chemistry — overlaps with ComInnex's chemistry offerings but operates at much greater scale across multiple geographies.
- Eurofins Discovery: Eurofins Discovery is a global discovery services arm of Eurofins Scientific offering medicinal chemistry, custom synthesis, and screening services — comparable in service offering to ComInnex but with a much broader portfolio and global reach.
- Charles River Laboratories: Charles River Laboratories is a major global CRO with discovery and safety assessment services including synthetic chemistry — competes with ComInnex for chemistry services but operates as a much larger, broader incumbent with a full service portfolio.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
ComInnex social profiles
Digital presenceComInnex financial estimates
Financial estimateRevenue estimate
Valuation estimate
ComInnex leadership team
Management profileNumber of profiles
Profiles1 record
ComInnex funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ComInnex M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ComInnex
What does ComInnex do?
ComInnex provides synthetic chemistry services and develops novel chemical technologies to support early-stage drug discovery. The company's work underpins compound preparation, route development, and chemistry-enabled discovery activities performed on behalf of pharmaceutical and biotechnology clients.
When was ComInnex founded?
ComInnex was founded in 2009. It employs 1 to 10 people.
Where is ComInnex based?
ComInnex is headquartered in Budapest, Hungary, in the Europe region.
Who are ComInnex's main competitors?
Direct peers on record are Selvita, ChemPartner, Sygnature Discovery, Sai Life Sciences, Aragen Life Sciences, Concept Life Sciences and BioAscent. Broad incumbents are Pharmaron, Eurofins Discovery and Charles River Laboratories.
Does ComInnex have an API?
No public API is recorded for ComInnex.
What industry is ComInnex in?
ComInnex's product category is Drug Discovery Chemistry Services. Its primary akta.pro industry code is HLAGAHAE, Chiral / Asymmetric Synthesis & Complex Chemistry Services, with a secondary code of HLAAAIAL, Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries). Its NAICS code is 5417 and its SIC code is 8731.